Clearmind Medicine Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Clearmind Medicine Inc. (CMND) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingOct 2025Oct 2024Oct 2023Oct 2022Oct 2021Oct 2020
Operating Activities
Net Income-3.86-5.25-8.62-6.89-3.00-0.31
Depreciation & Amortization0.050.050.060.080.010.14
Deferred Income Tax0.070.100.020.030.000.00
Stock Based Compensation0.811.000.831.210.680.00
Change in Working Capital-0.04-0.13-0.971.240.02-0.02
Change in Accounts Receivable0.020.06-0.150.02-0.130.00
Change in Accounts Payable0.08-0.20-0.791.120.28-0.01
Change in Other Working Capital0.210.010.000.01-0.13-0.02
Other Operating Activities0.210.010.000.010.000.00
Net Cash from Operating Activities-4.73-4.86-6.30-3.72-2.29-0.20
Investing Activities
Capital Expenditures0.000.000.00-0.01-0.03-0.01
Purchases of Investments-0.71-0.350.000.000.000.00
Sales/Maturities of Investments0.190.080.000.00-0.160.00
Other Investing Activities-0.010.03-0.030.00-0.020.00
Net Cash from Investing Activities-0.54-0.24-0.03-0.01-0.200.00
Financing Activities
Debt Repayment-0.04-0.04-0.04-0.070.000.00
Common Stock Issued0.422.1911.120.585.930.45
Other Financing Activities0.000.000.000.00-0.600.00
Net Cash from Financing Activities2.626.2511.660.515.930.45
Summary
Effect of Forex Changes on Cash0.00-0.01-0.04-0.020.000.00
Net Change in Cash-2.651.165.34-3.223.440.25
Cash at Beginning of Period6.575.430.133.370.240.00
Cash at End of Period3.926.575.430.133.370.00
Free Cash Flow-4.73-4.86-6.30-3.73-2.31-0.21
Supplemental Disclosures
Interest Paid0.000.010.000.010.000.00
Income Taxes Paid0.230.310.010.000.000.00